Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions.
暂无分享,去创建一个
J. Neal | Gregory Riely | D. Costa | P. Janne | A. Tsao | D. Camidge | L. Bazhenova | S. Gadgeel | L. Horn | J. Patel | A. Spira | H. West | Z. Piotrowska | V. Zhu | Shuanglian Li | S. Vincent | Jian Zhu